BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Aug 10, 2018
Company News

China Medical gains rights to Can-Fite's ADORA3 agonists

Read More
BioCentury | Jul 18, 2016
Clinical News

Piclidenoson: Phase II data

Read More
BioCentury | May 11, 2015
Clinical News

IB-MECA: Additional Phase II/III data

Read More
BioCentury | Apr 20, 2015
Company News

Can-Fite, Cipher deal

Read More
BioCentury | Apr 6, 2015
Analyst Picks & Changes

Analyst picks & changes

Read More
BioCentury | Apr 6, 2015
Clinical News

IB-MECA: Phase II/III data

Read More
BioCentury | Nov 24, 2014
Analyst Picks & Changes

Analyst picks & changes

Read More
BioCentury | Jun 30, 2014
Clinical News

IB-MECA: Completed Phase II/III enrollment

Read More
BioCentury | Jun 23, 2014
Clinical News

IB-MECA: Development discontinued

Read More
BioCentury | Jun 23, 2014
Clinical News

IB-MECA: Phase II amended

Read More
Items per page:
1 - 10 of 68